Objective:The purpose of this study was to investigate the placental passage of granulocyte-macrophage colony-stimulating factor in a placental perfusion model ex vivo.
Methods:In an open system, 11 placentas were perfused on both the maternal and the fetal side immediately after delivery. Granulocyte-macrophage colony-stimulating factor was added to the maternal perfusion medium in concentrations from 10-55 μg/mL. Maternal and fetal samples were taken, and granulocyte-macrophage colony-stimulating factor (GM-CSF) was measured by enzyme-linked immunosorbent assay.
Results:Accumulation of granulocyte-macrophage colony-stimulating factor in the fetal circuit averaged 2.42% of the concentration added initially to the arterial portion of the maternal circuit.
Conclusion:There is only low transfer of GM-CSF across the fetal membranes. This finding is particularly remarkable in view of recently published results suggesting that administration of recombinant granulocyte growth factors to pregnant women with imminent preterm delivery helps prevent neonatal sepsis.
1. Fanaroff a, Korones S, Wright L, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth weight infants. N Engl J Med1994;330:1107-1113.
2.
2. Ohls RK, Li Y, Abdel-Mageed A, Buchanan G, Mandell L, Christensen RD. Neutrophial pool sizes and granulocyte colony stimulating factor production in human mid-trimester fetuses. Pediatr Res1995;37:806-811.
3.
3. Cairo M, Suen Y, Knoppel E, van de Ven C, Nguyen a, Sender L. Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared with adults. Pediatr Res1991;30:362-367.
4.
4. Cairo M, van de Ven C, Toy C, Mauss D, Sender L. Recombinant human granulocyte-macrophage colony-stimulating factor primes neonatal granulocytes for enhanced oxidative metabolism and chemotaxis. Pediatr Res1989;26:395-395.
5.
5. Cairo M, Christensen R, Sender LS, et al. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birth weight neonates: Significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood1995;86:2509-2515.
6.
6. Schneider H, Pangl M, Dancis C. Transfer across the perfused human placenta of antipyrine, sodium, and leucine. Am J Obstet Gynecol1972;114:822-828.
7.
7. Brandes JM, Tavoloni N, Potter BJ, Sarkozi L, Shepard MD, Berk PD. A new recycling technique for human placental cotyledon perfusion: Application to studies of the fetomaternal transfer of glucose, insulin, and antipyrine. Am J Obstet Gynecol1983;146:800-806.
8.
8. Reisenberger K, Egarter CH, Vogl S, Sternberger B, Kiss H, Husslein P. The transfer of interleukin-8 across the human placenta perfused in vitro. Obstet Gynecol1996;87:613-616.
9.
9. Sekino H, Moriya K, Sugano T, Wakabayashi K, Okazaki A. Recombinant human G-CSF (rG-CSF). Shinryo Shinyaku1989;26:32-104.
10.
10. Christensen RD, Rothstein G. Exhaustion of mature marrow neutrophils in neonates with sepsis. Pediatrics1980;96:316-318.
11.
11. Marsh JC, Boggs DR, Cartwright GE, Wintrobe MM. Neutrophil Kinetics in acute infection. J Clin Invest1967;46:1943-1953.
12.
12. Wheeler JG. Neutrophil storage pool depletion in septic, neutropenic neonates. Pediatr Infect Dis1984;3:407-409.
13.
13. Cairo M, Worcester C, Rucker R, et al. Randomized trial of granulocyte transfusion versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr1992;120:281-285.
14.
14. Calhoun DA, Rosa C, Christensen RD. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol1996;174:1306-1311.
15.
15. Novales JS, Salva AM, Modanlou HD, et al. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection. Blood1993;81:923-927.
